Ad
related to: when to treat hyperphosphatemia meaning in pregnancy calculator- Phosphate Binder FAQs
Get Answers To Frequently Asked
Phosphate Binder Questions.
- How The Treatment Works
Learn How A Phosphate Binder
Treatment Works - Watch A Video.
- Impact Of High Phosphorus
Learn More About The Impact
Of High Phosphorus Levels.
- Savings Information
Download A Savings Card For A
Phosphate Binder Treatment Option.
- Dialysis Patient Support
Read Helpful Resources & Visit An
Official Phosphate Binder Site.
- Your Guide To Phosphorus
Download The Patient Guide
To Learn More About Phosphorus.
- Phosphate Binder FAQs
Search results
Results From The WOW.Com Content Network
Hyperphosphatemia. Hyperphosphatemia is an electrolyte disorder in which there is an elevated level of phosphate in the blood. [1] Most people have no symptoms while others develop calcium deposits in the soft tissue. [1] The disorder is often accompanied by low calcium blood levels, which can result in muscle spasms.
Sevelamer (rINN) is a phosphate binding medication used to treat hyperphosphatemia in patients with chronic kidney disease. When taken with meals, it binds to dietary phosphate and prevents its absorption. Sevelamer was invented and developed by GelTex Pharmaceuticals. Sevelamer is marketed by Sanofi under the brand names Renagel (sevelamer ...
Sucroferric oxyhydroxide. Sucroferric oxyhydroxide, sold under the brand name Velphoro, is a non-calcium, iron-based phosphate binder used for the control of serum phosphorus levels in adults with chronic kidney disease (CKD) on haemodialysis (HD) or peritoneal dialysis (PD). [6] It is used in form of chewable tablets.
Phosphate binder. Phosphate binders are medications used to reduce the absorption of dietary phosphate; they are taken along with meals and snacks. They are frequently used in people with chronic kidney failure (CKF), who are less able to excrete phosphate, resulting in an elevated serum phosphate.
Denial of care in chronic kidney disease treatment and management is a significant issue for minority populations. This can be due to healthcare provider bias, structural barriers, and health insurance coverage disparities. Healthcare provider biases can lead to under-treatment, misdiagnosis, or delayed diagnosis.
Fetal-maternal haemorrhage is the loss of fetal blood cells into the maternal circulation. It takes place in normal pregnancies as well as when there are obstetric or trauma related complications to pregnancy. Normally the maternal circulation and the fetal circulation are kept from direct contact with each other, with gas and nutrient exchange ...
Based on a survey conducted in 2022, Nephrologists stated that the greatest unmet need in the treatment of hyperphosphatemia with phosphate binders is a lower pill burden and better patient compliance. 1 The global market opportunity for treating hyperphosphatemia is expected to exceed $2.5 billion, with the United States accounting for more ...
A heterotopic pregnancy is a complication of pregnancy in which both extrauterine (ectopic) pregnancy and intrauterine pregnancy occur simultaneously. [2] It may also be referred to as a combined ectopic pregnancy, multiple‑sited pregnancy, or coincident pregnancy. The most common site of the extrauterine pregnancy is the fallopian tube.
Ad
related to: when to treat hyperphosphatemia meaning in pregnancy calculator